Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|September 24, 2016
Serum uric acid levels and the risk of flares among gout patients in a US managed care settingAki Shiozawa, Erin K Buysman, Stephanie Korrer
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2018
Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysisErin K Buysman, Rachel Halpern, David W Polly
Advances in Therapy|April 3, 2015
Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort studyErin K Buysman, Fang Liu, Mette Hammer, et al.
Advances in Therapy|March 3, 2017
Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving CanagliflozinErin K Buysman, Amy Anderson, Shaffeeulah Bacchus, et al.
Clinical Therapeutics|May 22, 2012
Costs and clinical outcomes associated with use of ranolazine for treatment of anginaCharles E Phelps, Erin K Buysman, Gabriel Gomez Rey
Journal of the American Heart Association|April 27, 2019
Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart FailureNancy M Albert, Jason P Swindle, Erin K Buysman, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulinErin K Buysman, Tao Fan, Cori Blauer-Peterson, et al.
Diabetes Technology & Therapeutics|April 17, 2014
Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysisLin Xie, Steve Zhou, Brett W Pinsky, et al.
Current Medical Research and Opinion|October 31, 2014
Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world settingErin K Buysman, Wing Chow, Henry J Henk, et al.
BMC Endocrine Disorders|November 4, 2015
Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysisErin K Buysman, Wing Chow, Henry J Henk, et al.
Pageof 4